Upstream Bio, Inc. (UPB) financials · rev $2.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Upstream Bio, Inc. (UPB) rev $2.9M.
| Line | FY2025 | FY2024 | Pro (1 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $2.85M | $2.37M | |
| Operating Income | −$160.36M | −$77.76M | |
| Net Income | −$143.44M | −$62.81M | |
| EPS (Diluted) | −$2.66 | −$5.58 | |
| Unlock 3 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (1 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $353.77M | $481.72M | |
| Current Assets | $351.80M | $479.16M | |
| Cash & Equivalents | $101.58M | $325.89M | |
| PP&E | $559.00K | $582.00K | |
| Total Liabilities | $14.00M | $11.87M | |
| Current Liabilities | $13.45M | $10.74M | |
| Shareholders' Equity | $339.77M | $469.85M | |
| Retained Earnings | −$334.22M | −$190.78M |
| Line | FY2025 | FY2024 | Pro (1 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$133.28M | −$59.17M | |
| CapEx | $165.00K | $511.00K | |
| Investing Cash Flow | −$93.48M | −$59.48M | |
| Financing Cash Flow | $2.44M | $418.91M | |
| Net Change in Cash | −$224.31M | $300.25M | |
| Free Cash Flow | −$133.44M | −$59.68M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is UPB P/E and revenue?
Upstream Bio, Inc. (UPB) rev $2.9M.
What is UPB revenue?
Upstream Bio, Inc. last cached revenue is $2.85M (FY2025).
Is UPB profitable?
Upstream Bio, Inc. last cached net income is -$143.4M (FY2025).
What are UPB total assets?
Upstream Bio, Inc. last cached total assets are $353.8M (FY2025).
What is UPB free cash flow?
Upstream Bio, Inc. last cached free cash flow is -$133.4M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.